Plenary Speakers

  Wednesday, March 16

REGULATION OF SYNAPTIC FUNCTION BY ALZHEIMER’S ASSOCIATED GENES

  Thomas Sudhof (USA)

FLUID AND PET IMAGING BIOMARKERS FOR ALZHEIMER’S AND PARKINSON’S DISEASES

  Oskar Hansson (Sweden)

KEY MILESTONES IN ALZHEIMER’S DISEASE

  Samantha Budd-Haeberlein (USA)

  Thursday, March 17

DISEASE MODIFICATION IN PD: WHAT ARE THE PROMISING TARGETS?

  Anthony Lang (Canada)

  Friday, March 18

TAU AND DIVERSITY OF DRIVERS IN ALZHEIMER DISEASE

  Bradley Hyman (USA)

  Saturday, March 19

MICROGLIAL TAM RECEPTORS IN ALZHEIMER’S DISEASE

  Greg Lemke (USA)

  Sunday, March 20

STOMPING OUT THE SPARK: TARGETING PYROGLU3 AMYLOID-BETA FOR THE TREATMENT OF ALZHEIMER’S DISEASE

  Cynthia Lemere (USA)